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Previous research studies and statistics have shown that despite widespread use of pain alle-
viation strategies and recommendations, pain is under treated in as many as 50% of patients 
receiving treatment for the disease report unrelieved pain (Ashley, 2008). 
 
The purpose of this study was to determine the factors contributing to unrelieved cancer pain 
in palliative care and to establish what can be done by nurses to improve the current pain 
management situation. 
 
A systematic literature review was carried out through NELLI electronic library. Four electron-
ic databases were used; PUBMED, CINAHL, Taylor & Francis, and SAGE. Following pre-
determined criteria of English language, full text articles, and articles published from 2005 to 
2014; a total of 10 articles were finally identified and analysed for the study. 
 
The findings revealed three main descriptive categories including professional barriers, sys-
tem barriers and patient barriers. The professional barriers entailed medical staff training 
and medical personnel attitudes. The system barriers entailed the health care system, laws 
and regulations as well as government economy whereas as the patient barriers included pa-
tient attitudes and the complex psychological milieu of cancer. 
 
Deductions from the findings were made of the nurses’ contribution and role in improving the 
situation and reducing the occurrences of unrelieved pain among cancer patients in palliative 
care. 
 
The ethical issues were considered at all times throughout the research process. An observa-
tion was made of insufficient knowledge and research on unrelieved cancer pain. Extensive 
research was recommended in light of this observation.  
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1 Introduction
 
The prevalence and management of pain in cancer patients has been widely studied and doc-
umented owing to the high and increasing number of people who suffer from different forms 
of cancer. According to the World Health Organization cancer statistics of 2012 an estimated 
14.1 million people worldwide were diagnosed with cancer annually. There were 32.6 million 
people living with cancer within 5 years of diagnosis in 2012 (International agency for re-
search on cancer 2012). 
 
Pain has been defined by the International Association for the Study of Pain (IASP) as “an un-
pleasant sensory and emotional experience associated with actual or potential tissue damage 
or described in such terms of damage” (American Pain Society 2008). 
Studies have shown that Pain, which can be caused by the disease itself or by treatments, is 
common in people with cancer, approximately 70% to 90% of people with advanced cancer 
experience pain (Lesage and Portenoy 1999).  
 
Bhavani (2006) mentions that “the prevailing view is that management of both cancer and 
acute pain is not quite very controversial because a clear relationship between the disease 
and the patient’s pain can be identiﬁed” (Bhavani 2006). And yet evidence demonstrates that 
pain is undertreated in the palliative care settings, contributing significantly to patient dis-
comfort and suffering at the end of life. “Studies suggest that as many as 30% of newly diag-
nosed cancer patients, 40% of those undergoing treatment, and 75% of those in the terminal 
phase of disease have unrelieved pain despite widespread use of pain alleviation strategies 
and recommendations. One study reported that more than 50% of cancer patients have in-
creased suffering requiring sedation in the last days of life”(Ferrell & Coyle 2006) 
 
“Unrelieved pain impairs health and quality of life of the sufferer and deprives patients and 
their families’ interaction with possibility of growth and reconciliation before death. It there-
fore diminishes society’s wellbeing” (Hospice and Palliative Nurses Association 2012). 
 
“The great difﬁculty of understanding the nature of chronic pain is that chronic pain sufferers 
often lack objective physical evidence that proves the existence of their pain. There is no 
“pain-o-meter. “Pain is an entirely subjective experience; pain is simply whatever the patient 
says it is. Because pain assessment is entirely subjective, it is not as easily quantiﬁed as 
pulse, blood pressure, temperature and respirations, although pain evaluation is now dubbed 
the “ﬁfth vital sign” (Bhavani 2006).  
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Dalal& Bruera (2009) state that “chronic pain in cancer patients is a multifaceted complex 
syndrome involving biological, psychological and social contributors and consequences various 
factors influence the production, perception and expression of pain including tumours, treat-
ment and individual characteristics e.g. genetic, emotional/cognitive status, sociodemo-
graphics and history of addition as well as the type of cancer, the stage of the disease, and 
the patient's tolerance.” These aspects must be considered in caring for patients with cancer 
in palliative care if the quality of life is to be improved.  
 
“The most common cancer pain is from tumours that metastasize to the bone. As many as 60 
to 80% of cancer patients with bone metastasis experience pain. The second most common 
cancer pain is caused by tumours infiltrating the nerve and hollow viscous. Tumours near neu-
ral structures may cause the most severe pain. The third most common pain associated with 
cancer occurs as a result of chemotherapy, radiation, or surgery” (Swierzewski, 2015). 
 
 
Since pain is very frequently emphasized among medical professionals, health care research-
ers and patients, its management is very vital particularly with metastasized cancer. It is in 
line with this that the WHO developed the three- step pain ladder where the first step is the 
use of non-opioids, the second being opioids for mild to moderate pain and finally opioids for 
moderate to severe pain. The WHO guidelines have been used as a basis for the formulation 
and constant update of European pain management guidelines first in 2003 then 2007, the 
current edition with partial updates is that of 2013 which is has an expanded section 3.5 ded-
icated to palliative care (European Association of Urology, 2013). 
 
The American pain society (2008) however points out that not all people with cancer do expe-
rience pain in spite of the attention to drawn to pain.  
 
The purpose of this study is to determine the factors contributing to unrelieved pain among 
cancer patients in palliative care using a systematic literature review. 
This is with the aim of finding ways in which nurses can contribute to improving the current 
pain management situation. 
The guiding research question to this purpose is as follows: 
What can be done by nurses to improve the current pain management situation? 
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2 Definition of key concepts 
 
2.1 Unrelievedpain 
 
Coyle and Layman-Goldstein, (2001) define unrelieved pain as “ a persistent unpleasant sen-
sory and emotional experience associated with actual or potential tissue damage or described 
in such terms of damage and that this kind of pain normally eludes standard medication and is 
continuous, leaving the patients in a state of constant discomfort.”  
The European pain federation (2012) refers to unrelieved pain as that pain which is chronic or 
recurrent. It is a major healthcare problem and a disease in its own right even though it is 
considered a symptom of disease. 
According to Coyle and Layman-Goldstein (2001), unrelieved pain exhibits the following char-
acteristics 
 persists more than 3 months 
 adaptation of autonomic system occurs 
 objective signs of pain are not exhibited 
 contributes to fatigue, depression, insomnia, general despair, withdrawal and desire 
for death if poorly managed 
 is frequently unrecognized, untreated or under-treated 
 
2.2 Cancer 
 
“It is a class of diseases characterized by out-of-control cell growth. There are over 100 dif-
ferent types of cancer, and each is classified by the type of cell that is initially affected” 
(Crosta, 2015). 
“Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of 
tissue called tumours except in the case of leukaemia where cancer prohibits normal blood 
function by abnormal cell division in the blood stream. Dangerous, or malignant, tumours can 
grow and interfere with the digestive, nervous, and circulatory systems, and they can release 
hormones that alter body function.” 
“When a tumour successfully spreads to other parts of the body and grows, invading and de-
stroying other healthy tissues, it is said to have metastasized. This process itself is called me-
tastasis, and the result is a serious condition that is very difficult to treat” (Crosta, 2015). 
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2.3 Palliative care 
 
Palliative care is “an approach that improves the quality of life of patients and their families 
facing the problem associated with life-threatening illness, through the prevention and relief 
of suffering by means of early identification and impeccable assessment and treatment of 
pain and other problems, physical, psychosocial and spiritual”(WHO, 2002). 
World Health Organisation provides the following as the provisions for palliative care 
 provides relief from pain and other distressing symptoms; 
 affirms life and regards dying as a normal process; 
 intends neither to hasten or postpone death; 
 integrates the psychological and spiritual aspects of patient care; 
 offers a support system to help patients live as actively as possible until death; 
 offers a support system to help the family cope during the patients illness and in their 
own bereavement; 
 uses a team approach to address the needs of patients and their families, including 
bereavement counselling, if indicated; 
 will enhance quality of life, and may also positively influence the course of illness; 
 Is applicable early in the course of illness, in conjunction with other therapies that 
are intended to prolong life, such as chemotherapy or radiation therapy, and includes 
those investigations needed to better understand and manage distressing clinical 
complications (WHO 2002). 
 
In Finland, Palliative care is a” continual form of treatment, conducted in a way that is sensi-
tive to the dignity of a patient and significant to the quality of life of patients and their close-
ones. The aim is to make death as free of symptoms and free of apprehension as possible, and 
to ensure that relatives and friends are in a position to cope with the patient’s death” 
(Cancer society of Finland, 2009). 
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3 Purpose statement and research questions 
 
The purpose of this study is to determine the factors contributing to unrelieved pain among 
cancer patients in palliative care.  
This is with the aim of finding ways in which nurses can contribute to improving the current 
pain management situation? 
 
Research question 
What factors are contributing to unrelieved pain among cancer patients in palliative care? 
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4 Methodology 
 
4.1 Literature review 
A systematic literature review was used during data collection in this research. This was in a 
bid to summarize previous studies on unrelieved pain among cancer patients in palliative care 
in order to answer the research questions. A qualitative approach was used. The methodology 
implementation included a number of steps in order to convert the research questions into a 
research, and identify current knowledge with regard to relevant concepts and contexts. 
These included reference to keywords, literature search from predefined databases, limiting 
the search by setting a criteria, literature filter by criteria. 
 
A systematic review was used as it seeks to bring together relevant literature in detail for 
review in order to gain the information and knowledge about a specific topic (Aveyard 2010). 
Literature reviews have also been traditionally used in health care literature, used widely to 
sum up previously researched literature focusing on a particular research question. They offer 
a reliable, transparent, clear and reproducible way of organizing, evaluating, analysing and 
interpreting existing evidence (Hemingway & Brereton, 2009). Thereby adding value by offer-
ing comprehensive search for information. 
 
A systematic search was conducted through predefinition a review protocol to obtain appro-
priate studies as suggested by Kitchenham (2004) in Procedures for Performing Systematic 
Reviews in which he stated that a “pre-defined protocol is necessary to minimize possible 
researcher bias.” A systematic review favours production of reliable findings that can conse-
quently be used to inform decision making as it uses explicit methods with the aim of reduc-
ing bias.  
 
4.2 Data sources and search 
 
The starting point for gathering data was an online search. The data was primarily accessed 
through the Laurea AMK electronic portal (NELLI) on recommendation by the Laurea AMK li-
brarian as a credible source for academic material. The aim of the preliminary search was to 
identify existing systematic reviews and assess the volume of potentially relevant studies. 
 
The research was carried out by two people. The predefined protocol was jointly decided up-
on by both researchers. The data search process was done in chronological steps which in-
cluded planning, searching, assessing and finally writing in order to maintain the systematic 
approach. Screening of titles and abstracts as well as reviewing potentially eligible full text 
articles was performed independently by the two reviewers. Cases of disagreement were dis-
cussed until a consensus was reached. 
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The research questions were narrowed down to major key search words namely, unrelieved 
pain, cancer patients, palliative care. There were no synonyms used as this effort only divert-
ed our focus to areas irrelevant to our study. 
An electronic search was performedduring10th December 2014- 29th January 2015infour da-
tabases. Taylor and Francis, and SAGE, PUBMED, CINAHL. 
Key search terms were separately searched in 2 main filters which included, unrelieved pain 
AND cancer patients, Unrelieved pain AND palliative care. This produced noticeably fewer and 
more relevant results. 
 
Literature filter was done by criteria of articles published between years 2005 to 2014, the 
text had to be written in English and had to be full text (except PubMed where free full Eng-
lish text was used). Contents of titles as well as abstracts was a filter for sources to be in-
cluded. Sources were selected for review when they met the criteria. The search from all da-
tabases produced a total of 236 articles. 219 articles were discarded and 17 were selected for 
evaluation from which 10 were selected for review. 
 
Table 1illustration of the data search process 
 
DATABASES SEARCHWORDS NO OF HITS RELEVANT NOT MEETING CRITE-
RIA 
Taylor and Francis 
Sage Journals 
Unrelieved AND pain 
AND 
Cancer patient, pallia-
tive AND care 
14 1 13 
Sage Publications Unrelieved AND pain 
AND 
Cancer AND patient AND 
palliative AND care 
84 6 78 
CINAHL Unrelieved AND 
 Pain ANDcancer ANDpal-
liative care 
 
2 0 2 
PUBMED Unrelieved AND pain 
AND 
Cancer AND palliative  
care 
135 3 132 
TOTAL  235 10 225 
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4.3 Inclusion and exclusion criteria 
 
The data were selected based on the research question and purpose statement with criteria 
to guide the process. Exclusions are set of predefined criteria used to identify subjects which 
will not be included or which will have to be withdrawn from a research study after being 
included, while inclusion criteria are set of predefined characteristics used to identify sub-
jects who will be included in a research study (Salkind 2010).  
Higgins and Green (2011) emphasized that the method used for this procedure must be trans-
parent to minimize biases and human errors. 
 
The inclusion criteria was in place to ensure that information is not too generalized in which 
case information would have been hard to compare and synthesize as pointed out by Centre 
for Reviews and Dissemination 2009. 
To be included, studies had to meet the following criteria; 
Studies had to focus on cancer patients from the age of 18 and above. Children fell into a 
category needing specialized care and treatment and we chose not to focus on them. 
The text had to be written in English language. This was set as such since it is the language 
both researchers could read and interpret well; using other language might have caused mis-
interpretation of information. The studies also had to be published between 2005 and 2014, 
this was to ensure that information is current. 
The study resources and articles had to be Full text in order to ensure that the relevant in-
formation was analysed in its complete form. 
 
Figure1. Below is an illustration of the processes of data selection. 
 
 
. 
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Figure 1 illustration of the processes of data selection 
 
 
 
 
 
 Database search. PubMed, CINAHL, Sage, Taylor &Francis      N=236 
SAGE N=84 
 
TAYLOR&FRANCIS N=14 
 
CINAHL N=3 
 
PUBMED N=135 
 
EXCLUSIONS N= 219 
 Articles not relevant based 
on titles and abstracts  
 INCLUSIONS FOR FURTHER REVIEW= 17 
-2005 - 2014 –  
-Abstract contained 1 or more of the search 
terms 
-Studies in English language 
-Full text Articles 
Abstract contained one or more search terms 
EXCLUSIONS N=7 
-Contents did not answer our 
research question (N=4) 
 -unrelieved pain not focused 
on cancer patients (N=2) 
-Article duplication (N=1) 
 
 
 
 
 
 
 INCLUSIONS N=10 
-Articles answered the research ques-
tion 
-scientific and evidence based arti-
cles 
 
 
 
 
 
ARTICLES ACCEPTED 
N=10 
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4.4 Data extraction 
 
The purpose of the data extraction was to extract findings in a consistent manner. According 
to Kitchenham (2004), this enables later data synthesis and interpretation. A data extraction 
form was required during the course of data extraction to accurately and unbiasedly record 
obtained information from primary studies as pointed out by Kitchenham (2004). It was de-
signed in consideration of the volume of selected information. The data extraction form was 
to play four main functions. To act as a summary of selected studies, to assess the eligibility 
of the current study because it directly links to the review questions and criteria, act as a 
historical record throughout the review process and  also to act as a resource of analysis as 
advised by(Higgins & Green, 2011). 
 
In this study, data was extracted from all the included studies by two reviewers independent-
ly. Extraction of data was done upon mutual agreement and reconciliation of differences, this 
was to establish reliability and avoid data entry errors (Wright, Brand, Dunn& Spindler 2007).  
Data extraction was based mainly on the purpose statement of this thesis in order to ensure 
that the data obtained was relevant to this study.  
This process was guided by the research questions and the extraction criteria. 
Where data contents overlapped, only data from the most recent source was considered. If 
essential material was missing from referenced original publications, the referenced article 
was sought for depth on the issue. All final selected data was agreed upon by two research-
ers. Selected articles needed for this study are listed showing the source, study objectives, 
title of articles, and participants during the study and findings in appendix 1 
 
4.5 Data Analysis 
 
Data analysis is the core step of the systematic literature review. It involves collating and 
summarising data extracted from primary studies (Kitchenham, 2004). 
In this study, qualitative approach of data analysis was used to answer the writers’ research 
questions by systematically exploring researches on a topic, and putting the findings from 
selected studies together (Seers 2012). 
 
A thematic analysis was employed to summarise information in the articles with the aim of 
identifying and bringing together emerging, recurring themes in the literature. Thematic 
analysis aims at “preserving data in its original form” as mentioned identified by Coughlan, 
Cronin & Ryan (2013). There was no data transformation in a bid to maintain accuracy and 
reduce personal bias. The data analysis process was done by both reviewers in two face-face 
meetings and 3 Skype video calling sessions. 
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A coding system was used to outline the main points being made in the literature. Since the 
studies being reviewed included both research and non-research literature, the coded infor-
mation came from both the findings and discussion sections respectively. Once the initial 
codes were made from each study, the next step eliminated replications, highlighted emerg-
ing themes and grouped the codes that had similarity categorically as illustrated below. 
 
Figure 2Main themes and categories of contributing factors to unrelieved cancer pain 
RAW DATA  SUB-CATEGORIESMAIN CATEGORY 
 
 
   MEDICAL PERSONNEL PROFESSIONAL 
 ATTITUDES BARRIERS 
 
 
   MEDICAL STAFF 
 TRAINING/EDUCATION 
 
 
 
 LAWS AND  
 REGULATIONS 
 
 SYSTEM 
 BARRIERS
   
 
 HEALTH CARE 
 SYSTEM 
 
 
 GOVERNMENTS´ 
 ECONOMY 
 
 
 
 
  COMPLEX PYSCHOLOGICAL 
 MILIEU OF CANCER 
 PAIN  PATIENT 
 BARRIERS 
 
 PATIENTS ATTITUDES 
 AND PERCEPTIONS 
 
-Distrusting patients’ pain 
-Resist becoming vulnerable to patients 
-Fear of creating drug addicts and opio-phobia  
-Pain is not viewed as a physical illness 
-pain treatment is not prioritised 
 
-Misinformation about opioids 
-Misapprehension about existence of chronic pain 
-Physicians training/ inadequate training 
-Methods of pain evaluation 
-Inappropriate diagnosis 
 
 
-Fear of legal repercussions by law enforcement agencies 
-Healthcare system Restrictions  
-Morphine is used less in comparison to other drugs 
 
-Opioid diversion at end of life/home settings 
-Lack of accountability for insufficient treatment 
-Fragmentation of care among different providers 
-Comorbidities that require additional medication and   
intervention 
-lack of referral to supportive care services 
 
 
-Poor resources in developing countries 
-Unavailability of morphine 
-Limited access to opioids 
-Opioid wholesale prices differ across the world 
-EU not united in opioid use 
-Large variation in the use of opioids 
 
-Tolerance to morphine and other opioids 
-History of substance misuse and self-medication 
-Existential factors contributing to drug seeking 
-pain perception, inner state of suffering  
-Multifaceted character of cancer pain 
-age and comorbidities 
 
-Patients under reporting pain 
-Fear of opioid addiction and side effects 
-Fear of stigmatisation  
-Misconception about pain drugs 
-Communication problems/non communicative patients 
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5 Findings 
This section presents the findings of the research study based on 10 reviewed articles in rela-
tion to the purpose statement and research questions. The findings related to factors contrib-
uting to unrelieved cancer pain are presented under three main descriptive categories.  
 
Figure 3Factors contributing to unrelieved cancer pain 
 
 
 
5.1 Professional barriers 
 
Three articles discussed significant health care professional barriers to adequate cancer pain 
relief. These were put into two categories including medical personnel attitudes and medical 
personnel training. 
 
5.1.1 Medical personnel attitudes 
 
Bhavani (2006) argues in a review article that the fear of creating drug addicts by placing 
chronic pain sufferers on opioids for extended periods of time reduces the likelihood of pain 
treatment success as this fear and ignorance pervades the mind-sets of society and shapes the 
development of laws and ultimately affect, and even deter the physician’s practice of pain 
management. 
Bhavani (2006) argues further as far as medical personnel attitudes are concerned that there 
is a misapprehension about the existence of chronic pain in the health care system and that 
therefore distrusting patients’ pain is a contributing factor to it’s under management stating 
that Patients often lack objective physical evidence that proves the existence of their pain. 
There is no “pain-o-meter” or bright line litmus test to objectively verify a patient’s level of 
pain. Physicians do not trust patients’ subjective experience since it is not as easily quantiﬁed 
as pulse, blood pressure, temperature and respirations. Patients’ self-reports of pain at face 
Factors contributing to 
unrelieved cancer pain
professional 
barriers
system barriers patient barriers
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value are left as the most reliable indicator of the existence and intensity of pain making 
hard to manage effectively. 
 
Rowley, Mclean, O’Gorman, Ryan, & McQuillan(2010) argue that patients with a history of 
substance misuse were less likely to be prescribed strong analgesics than those with no such 
history, due to concerns regarding adverse effects of opioids, or concerns regarding iatrogenic 
opioid dependence and thus reported more uncontrolled symptoms and more psychiatric dis-
tress associated with unrelieved pain. 
 
In a qualitative study by Gibbins, Bhatia, Forbes& Reid (2013), participants discussed the role 
of healthcare professionals and the culture around pain within the medical profession. They 
acknowledged that they did not perceive that pain was important to healthcare professionals, 
and these thoughts were consolidated in that they were rarely asked about it routinely. One 
subject states, 
“I honestly think, when you’ve got something wrong with you like liver cancer and bone cancer and all 
of this, they want to treat your problem, the liver cancer and all of it. Pain comes like second they want 
to try and cure your cancer with treatment, chemo, this, that and all of it….” 
 
5.1.2 Medical staff training and education 
 
Chih-Yi Sun, Borneman, Ferrell, Piper,Koczywas, Choi (2009) highlight inadequate education 
and training in cancer pain assessment as major contributor to unrelieved pain in a study con-
ducted on 38 cancer palliative patients. There was a gap in the screening, re-assessment, and 
follow-up evaluations of pain. Overall, only 7.8% of subjects were screened for pain at each 
clinic visit. There was no correlation with pain rating documentation and re-assessment at 
subsequent follow-up visits. Only 2.6% of subjects had the quality of their pain documented. 
Seventy-six percent of patients had pain ratings of moderate severity (4–6) and 24% had se-
vere pain (7–10). There was very limited (7.9%) documented pain screening, no documenta-
tion of numerical pain ratings or evidence of reassessment. 
 
Misinformation about opioids and lack of sufficient opioid education was cited as a contrib-
uting factor to unrelieved pain. Bhavani(2006) argues in his review that In an effort to avoid 
prescribing opioids, many physicians make a frequent error in the treatment of chronic pain 
by prescribing substitute classes of medication, namely non-steroidal anti-inﬂammatory drugs 
(NSAIDS) and COX-2 inhibitors which may be insufficient in chronic pain treatment. 
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5.2 System barriers 
The system barriers were sub categorised unto three parts including laws and regulations, 
healthcare system and the government economy. 
 
5.2.1 Laws and regulations 
 
Bhavani (2006) argued in his review that despite the efficacy of opioids in the treatment of 
chronic pain, fear of increased regulatory scrutiny criminal investigation or even criminal 
prosecution by state medical licensing boards and drug enforcement agencies is another 
prominent reason for the under prescribing of opioids that may in turn contribute to unre-
lieved pain. 
He added that often, regulations regarding prescribing of opioids are vague and ambiguous, 
causing physicians to be uncertain about what constitutes legitimate opioid use. 
 
5.2.2 Healthcare system 
 
Chih-Yi Sun et al (2009) cites lack of referral to supportive care services as a contributor to 
unrelieved cancer pain as no patients in the 39 subject study sample received a consult to a 
pain specialist and there was no documented pain education. Only 5.2% of subjects received a 
social work consult and there were no other psychosocial support consults. 
One overall observation was that patients seen in the outpatient clinic setting had much less 
supportive care available as compared to the inpatient setting. 
 
Gilson, Maurer, Le Baron, Ryan, Cleary (2012) in a multivariate study of 177 countries found a 
direct overall association between the aggregate consumption of five opioids (including mor-
phine) and the level of palliative care development in country’s healthcare system even when 
controlling for influences of the other predictor variables. 
 
In a review article on Palliative Care in Gynaecologic Oncology, Rezk, Timmins &Smith (2011) 
cites fragmentation of care among various providers and lack of accountability for insufficient 
pain treatment. The statement did not provide reference to the context of information. 
 
Opiate diversion is cited in a case presentation article by Baumrucker, Carter, Vanderkieft, 
Stolick, Harrington, Sheldon, Morris (2009) as a contributing factor to unrelieved pain as a 
result of the health care system structure which facilitates outpatient hospice control and the 
right to die at home. Palliative care provided in the home setting gives countless individuals 
access to pain medicine originally intended for the dying person and opens doors for opioids’ 
abuse by caretakers. 
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There are currently no established recommendations to guide practice in managing cancer 
pain in patients with a history of substance misuse on MMT. 
 
Rowley et al (2010) in a study reviewing Cancer Pain Management in Patients Receiving 
Maintenance Methadone Therapy presents underlying comorbidities as a contributing factor  
Patients may have comorbidities such as HIV/AIDS, which may require additional interventions 
and medications, complicating management of their pain. 
They add that Patients may have previous experiences substance abuse or self-medicating to 
remove pain and psychological distress, and in particular, dependence on substances such as 
benzodiazepines and alcohol has been shown to be a poor prognostic indicator for cancer pain 
control. Misusers may have frequent episodes of intoxications and withdrawal, which may al-
ter the intensity of their pain experience, making it harder to manage. 
 
5.2.3 Governments 
 
Gilson et al (2012) relay in a Multivariate analysis of how a countries' government and health-
care system influences on opioid availability that an inadequate national opioid distribution 
system and government and health-care system infrastructure can affect its opioid consump-
tion level. They add that although opioids such as morphine are considered essential medi-
cines in the provision of palliative care and for treating cancer pain, middle-income countries 
often lack such medications. 
The multivariate study results on 177 countries showed that commitment and extent of gov-
ernment spending on resources to health positively predicted the aggregate consumption of 
opioids indicated for treating severe pain e.g. the purchasing of essential medicines or financ-
ing educational initiatives for practitioners on the use of opioids for pain management was 
deemed to influence opioid consumption patterns. 
Adherence to international treaty obligations also predicted higher opioid consumption. 
 
In a 2005 editorial, Dale, Klepstad & Kaasa point to a review on the use of opioid analgesics in 
different European countries and presented data on the sales of opioids (codeine, tramadol, 
morphine and fentanyl in nine European countries from 2001 to 2003 which observed that  
morphine is used little in comparison to the other drugs,  there are large variations in the use 
of opioids both in respect to total consumption and choice of opioids between European na-
tions, the trends with respect to an increase and decrease in the use of opioids vary between 
countries and opioid wholesale prices differ considerably between countries. 
This editorial however presented second hand research information that is not current. 
 
5.3 Patient barriers 
These are the contributing factors to unrelieved pain that were directly stemming from the 
patients or appeared to be channelled through them. 
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5.3.1 Patients attitudes and perceptions 
 
Gibbins (2014) et al, In Qualitative study of what patients with advanced incurable cancer 
want from the management of their pain, talked about the sedative side effects of patients 
medication, which made them reluctant to take more among which they indicated that day-
time sleepiness was a threat to their usual self thus contributing to unrelieved pain.  Shown in 
the face-face interviews. “Yeah it does make you sleepy. Oh you start illusions and all sorts of things, 
you know, if you have too much of it.” (Charles) 
Interviewer: “And what worries you about increasing your medication up?  
Michael: “Well I take so much now. (Laughs) I’m sleeping” 
 
Patients expressed that they wanted to be pain free but did not actually expect to be ‘free of 
pain completely’ or ‘painless’, they wanted to ‘take the edge off’, ‘ease up’ or ‘keep a grip’ 
on the pain. “…So I know it’s not going to be terribly likely; there’s always going to be some level of 
discomfort somewhere”. (Mary) 
This perception that pain is inevitable in cancer or is to be expected contributes to it being 
unrelieved in palliative care.  
 
Almost all of the 12 participants reported not using their medication as prescribed, which 
frequently led to a ‘vicious cycle’ whereby they took only enough medications to ‘take the 
edge off’. Patients admitted to an attitude of taking the medications only when they felt pain 
was interfering with their everyday tasks or when they were becoming dependent on others. 
“But of course there’s always this er – this feeling that if you haven’t got any pain, why take drugs? Why 
take something? So it took a little while to kind of get over, you know, that. That you have to take the 
drugs even though you’re not in pain at that moment.” (Mary) 
“I don’t like taking any medication of any sort really until the pain gets sort of unbearable, and then 
I’ve got to take something.” (Charles) 
 
Underreporting pain was highlighted in the interviews as Patients acknowledged that they 
were reluctant to disclose pain perhaps because they were rarely asked about it, did not feel 
it was important to healthcare professionals and found it challenging to communicate their 
pain. E.g. “I normally wait for someone to ask me, you know, ‘How is your pain? How is your pain?’ and 
then you – then I’ll tell them.” (Sarah) 
In chin-YI-Sun’s study, subjects who were currently receiving chemotherapy treatments were 
more likely to believe that communication of pain might distract physicians from treatment 
of underlying disease more still Subjects with pain who were receiving chemotherapy were 
also more likely to believe that “good patients” do not complain about pain. 
 
 24 
Chih-Yi Sun (2009) et al, the study found that there was a strong belief that pain medicines 
are addictive, and that cancer patients are at high risk of developing addiction. 
 Subjects also believed that their body becomes tolerant to the effects of pain medicine and 
the medications would not provide pain relief in the future. 
 
Important knowledge deficits were seen as contributing factors to unrelieved pain as they 
existed with regards to the cause of pain, addiction with opioids, stopping pain medicine sud-
denly, and the need to increase pain medicine as being a sign of addiction. 
 
5.3.2 Multifaceted character of cancer pain 
 
Mori, Elsayem, Reddy, Bruera &Fadul (2011)  in a 3 case presentation of patients with cancer 
highlights a patient’s inner state of suffering, underlying psychosocial and or spiritual distress 
related to end-of- life issues as a common untreated contributing factor to unrelieved pain. 
These factors may influence pain perception and addressing the pathophysiology of pain alone 
without the other aspects contributing to suffering may be futile. They argued that unre-
vealed psychosocial distress resulting from physical, psychological, social, spiritual, and or 
practical issues may amplify pain expression and trigger a vicious cycle of increased pain ex-
pression, anxiety, escalation of opioids and benzodiazepine use, and impaired cognitive func-
tion. 
 
Rowley (2010) et al Study on cancer patients with a history of opioid misuse, relayed that if 
patients have had a history of substance abuse or self- medicating to remove pain and psycho-
logical distress they are prone to “chemical coping” which can become a barrier to optimal 
cancer pain management as dependence on substances such as benzodiazepines and alcohol 
has been shown to be a poor prognostic indicator for cancer pain control. Misusers may have 
frequent episodes of intoxications and withdrawal, which may alter the intensity of their pain 
experience. Prior abuse may leads to increased tolerance and refractoriness to analgesia from 
opioids other than methadone. They are also less likely to be prescribed strong analgesics 
than those with no such history, and thus reported more uncontrolled symptoms and more 
psychiatric distress than other patients. 
Rowley adds that patients’ fears of being stigmatized can further complicate management of 
their pain, as they may be fearful to disclose a history of past, or current, substance misuse 
in case needed pain medication is withdrawn. 
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5.4 Implication for healthcare practioners 
 
None of the studies directly referred to the nurse’s role in tackling and minimizing the prob-
lem of unrelieved cancer pain among patients in palliative care. The Nurses’ role/ involve-
ment was however deduced from areas where healthcare professionals were referred to as 
illustrated in the diagram below.  
 
Figure 4 Main themes and categories for interventions 
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6 Discussion 
 
This research set out to identify the contributing factors to unrelieved cancer pain in pallia-
tive care patients and how nurses could contribute to improving the current pain management 
situation. The findings of the study have a great implication on the nurses’ practice in the 
effort to decrease the occurrence of unrelieved pain in palliative care patients and can be 
incorporated in the wider context of nursing as discussed below. 
 
In order to maintain focus on our main topics of discussions, we make mention of our findings 
and base our discussions on them throughout the different subsections. 
Figure 5 below illustrates the main categories used in the discussion. 
 
Figure 5 how cancer pain management can be improved in palliative care 
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6.1 System Goals 
 
6.1.1 Assessment and Evaluation 
 
The lack of healthcare institutional mechanisms for routinizing the assessment and treatment 
of pain has been an attribute of unrelieved pain. One of the main objectives of palliative care 
for cancer patients is the relief of pain through different approaches but essentially, medica-
tion. According to our findings, pain is often undertreated because of factors arising from 
both the patients and the doctors. In some situations, patients do not report pain, in other 
instances, they do underreport pain. In instances when patients do report pain, some doctors 
are shown to respond by prescribing non opioid medications. Non opioids, though suitable for 
some kinds of pain, do not provide optimum pain relief to patients with advanced cancer. In 
reference to our findings, the fear among physicians of creating drug addicts and the stubborn 
refusal to acknowledge patients’ expressions of pain among some physicians is fundamental in 
the under treatment of pain. In this context, the role of the physicians could be seen as using 
their special skills to listen, assess, monitor/measure vital signs and in turn provide the nec-
essary pain treatment.  
The role of the nurse however, in cases where patients do report pain is to advocate for the 
patient. The ICN (2006) code of ethics for nurses mentions that for the nurse, primary respon-
sibility is to people requiring patient care and that a part of fulfilling that duty is assuming 
the advocacy role. Since pain assessment uses facial expressions and numbers 1- 10. I.e. med-
ical personnel must depend mainly on patients’ own description and expression of pain to 
commence any treatment on pain. The nurse being the patients’ immediate care giver is ethi-
cally obligated to trust the patient experience and advocate for/ represent the cause of the 
patient to prescribing physicians until the desired outcome of pain relief is achieved. The 
nurse has direct access to the physician and may be better able to paint clearly the patient 
situation/medical needs. 
 
More still, in cases where patients do not report pain, the nurse ought to use their own cancer 
palliative care expertise and judgment to ensure pain relief for the patients. This can be 
through directly inquiring from the patients about their pain experience, observing how far 
the patients engage in activities of daily living during their care work. Nurses could guide pa-
tients into describing when, how and the kind of pain experienced under different situations. 
The use of certain terms may go a long way into specific description of the pain experienced 
i.e. the relevant medication for its alleviation. This role is crucial because nurses spend most 
of their time close to their patients and they, in turn make reports to the physicians in charge 
about any health changes. In this situation, nurses can properly document and report the pain 
status as experienced during the care period. Some nurses learn to differentiate break 
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through pain and the normal chronic pain that patients with advanced cancer tend to experi-
ence. I.e. enabling the appropriate treatment as needed. 
 
6.2.2 Professional Training and Education 
 
In light of the above discussion, one would argue that doctors’ training ought to give them a 
better perspective on pain and its modalities. However, our findings point to misapprehension 
of pain by doctors and medical personnel in general. This therefore leads us to the specializa-
tion particularly by both doctors and nurses in palliative care. Training opportunities within 
the field greatly equip medical personnel in understanding, assessing and treating palliative 
cancer patients. Medical personnel who choose to train in this area are fundamentally en-
dowed with special assessment skills of disease progression, monitoring and the management 
of surrounding symptoms. An important area that is very well covered is pain management 
and control with the use of opioid medication. Pain modalities are important because this is 
no ordinary pain and will not respond to ordinary pain medications. Unlike general practition-
ers, palliative doctors and nurses have a better understanding of opioid use and are not afraid 
to increase doses or change medications when needed. Training of medical personnel there-
fore solves issues of misapprehension of pain as well as settling fears related to creating ad-
dicts of patients.  
Nurses in palliative care can rightfully take the initiative to ask for further training. As stipu-
lated in the healthcare act, the nurses have a right to this training should it be required. 
“Health centers shall be responsible for the provision of expedient multidisciplinary research, 
training, and development services” (Finnish Health care act 1326/2010). 
 
6.2.3 Governments and Healthcare System 
 
According to our findings the Human Development Index (HDI) of any given country measures 
the availability of resources towards national development issues including the provision of 
health care. In the context of our thesis, the differences in HDI between Lower Middle Income 
Countries (LMICs) and their developed partners account for disparities in the availability of 
resources dedicated towards palliative cancer care and treatment. In some LMICs, the lack of 
government commitment which is often worsened by limited education/information on the 
importance of palliative care has left very limited resources and in many instances no nation-
al policy on palliative care (Webster et al. 2007) i.e. heightening such disparities. The impli-
cation of limited/no resources towards palliative care means that majority of dying cancer 
patients have no access to interventions such as surgery, chemotherapy, radiation and opi-
oids. 
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Furthermore, despite international advocacy by bodies such as the World Health Organization 
(WHO) on the importance of opioids for intractable pain, many LMICs have very strict rules on 
the production and supply of opioids within their borders. Though strict controls may be legit-
imately aimed to curb abuse of opioids, they have at the same time impeded on medical per-
sonnel’s efforts to relieve chronic pain which is typical among advanced cancer patients. An-
other implication of limited national resources is the inability to afford large quantities of 
opioids to supply health systems and to enable the necessary training of medical personnel in 
the treatment and assessment of palliative cancer patients. 
 
With fragmentation in policy, knowledge and opioid supply often results fragmented interven-
tions. The consequences among others include limited/no pain relief at all or late referrals to 
palliative services for cancer patients. In the LMICs, such services are not always available 
nationwide (Webster et al. 2007) but only in the capital or city areas and within the private 
sector. 
Policy makers and health professionals need to understand why lifting unnecessary regulations 
is important for patients suffering painful conditions and nearing death. This can be achieved 
through engaging in advocacy and education about the need for palliative care services and 
correct opioid use (Webster et al. 2007). Education of policy makers and the general public 
can be done by the health care professionals who directly engage in the care of palliative pa-
tients and thus understand what kind of painful conditions and transitions they undergo. 
Nurses, doctors and other knowledgeable individuals should join their voices locally through 
educative fairs and with international bodies to advocate for the proper equipment and train-
ing of palliative care departments. Policies at the national levels will go a long way into 
providing favorable regulations for the supply of opioids and bringing palliative services closer 
to people. 
 
Our findings revealed that there is a large variation in opioid use between countries due to 
cultural differences. In Europe for example, the north- south divide point to the fact that Ita-
ly and Portugal as southern countries have a lower consumption of both morphine and fenta-
nyl where as in the United Kingdom, Norway and other northern countries are high consum-
ers. The reason cited is that people feel that to be able to tolerate pain is being ‘man-
enough’. Opinions are divided in this matter.  However socially constructed norms have a 
great influence on people’s daily lives including the pain relief. It can also be argued that, a 
culture of constant education and awareness of the general public pervades many northern 
countries enhancing awareness on many topical issues, in this case, cancer pain. Public 
knowledge makes it possible for individuals to make informed decisions on opioid use. In 
many developed countries, it is often the case that national televised campaigns, activities, 
special cancer days, ribbons, leaflets, advertisements and information is available through 
the media, making it possible to seek and find help. Participation of nurses in such events is 
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crucial because they can get to explain to the public the meaning of pain and suffering for 
palliative cancer patients. Cultures are developed through time, through constant awareness 
and education of the general public. Such cultures of evading opioid use can be slowly sup-
planted with informed scientific knowledge to the public.  
 
6.2 Alternative Approach 
 
6.2.1 Family Involvement. 
 
The best palliative cancer pain treatment ought to involve patients’ families and health care 
professionals. With the help of the family the patient and healthcare professionals particular-
ly nurses can establish realistic comfort and function goals. For example in the scenario, 
where the patient just wanted to be able to walk and do more chores at home, it would be 
hard to achieve total pain control at the same time due to  the  sedative effects of cancer 
pain medications.  
It was also evident in our findings that many patients prefer to spend the last days of their 
lives with loved ones in familiar surroundings. However, there are shortcomings associated 
with such settings. For example, family members are often physically and mentally derailed 
while taking care of loved ones, having opioids in home settings also runs the risk of diversion 
particularly if there is a dependent relative or caregiver. More still, patients may skip medi-
cation doses due to slight improvement in their pain or their general condition. Furthermore, 
the fear of the side effects of medications such as fear of addiction, sedation, constant fa-
tigue and restriction to bed may lead patients skipping some dosages until they feel totally 
compelled by the severity of pain or the disease. This defeats the objective of palliative care 
which is for the patients to have as pain free last days as possible.   
In direct relation to the above, the role of nurses becomes important because of their direct 
involvement in patient admission, stay and discharge from hospitals. The nurses’ role in edu-
cating patients and/or their loved ones on the how and when to take prescribed medications 
is vital. Patients ought to be informed about the use of the drugs, side effects and the impli-
cation of skipping or diverting medication. This will go a long way into preventing situations 
of helplessness due to untreated unrelieved pain. 
 
6.2.2 Newer Treatment and Diagnostic Modalities 
 
The importance of opioids in the effective treatment of various intractable painful conditions 
as is the case for cancer is undeniable. Newer medication modalities can be put in use for the 
effective management of cancer pain in a bid to reduce the cases of unrelieved cancer pain in 
palliative care. According to our findings, there are 3 steps in opioid use which involve the 
gradual increase in opioid medications from low to high doses with progressive cancer/pain in 
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patients and tolerance to the medications. Compared to other pain medications notably 
NSAIDs, opioids are very potent and can have a long half-life. Moreover, altering their admin-
istration routes to subcutaneous, intravenous and intrathecal makes some opioids ten times 
more potent than when administered orally or transdermally.  However, despite their effec-
tiveness, some factors about opioids make their use complicated and are thus worth address-
ing. For example, our findings portray that a history of opioid abuse may greatly compromise 
their effectiveness in future use. A past of opioid dependency could for example mean that a 
patient may require less opioids for the treatment of pain. In mentioning this, it is important 
to note that opioids can be used for a varied number of reasons including as analgesics for 
different kinds of pain, for the treatment of heroin addiction, to relieve anxiety and for 
chemical coping. It is thus inaccurate to believe that it is only people with a history of drug 
addiction per say who fall in the risk category of having a history of opioid use. Long term 
opioid use has been shown to induce neuroplastic changes which make the achievement of 
pain control more difficult than in patients who are opioid naive(Rowley et al. 2010).  
 
In addition to the above, the lack of uniform conversion scales for different opioids make 
their use complicated particularly given the varied half-life and potency. Switching to metha-
done for instance from morphine is complicated by variable half-life and potency ratios (Row-
ley et al. 2010). This factor is further complicated by the differences in individual pharmaco-
kinetics which literally means that, what applies to one person may not apply to another.  
Not only that, the stigma associated with opioid use often leads to denial or lack of mention 
among patients about previous or ongoing use or abuse of opioids. When medical personnel 
are ill equipped about a patient’s drug history, this tends to negatively affect the ongoing or 
prospective treatment. 
Due to their proximity to patients during the care process, nurses could contribute by gaining 
patient’s confidence in regard to opioid use. When reassured that their information will be 
treated confidentially as obligated by the Nurses’ oath, some patients may be forthcoming 
about a past of opioid use of any.  When attained, such information can go a long way in en-
hancing the palliative pain management process for such patients 
 
6.2.3 Multidisciplinary approach 
 
Though pain is a central aspect in palliative cancer care, it is important to note that pain is 
very dynamic - often negating one antidote. According to our findings direct sources of pain 
have been associated with surgical procedures, chemotherapy and metastasized tumors that 
often affect surrounding nerves, bones and the spine. Another source of pain is attributed to 
chronic co-morbidities such as diabetes, heart disease, osteoarthritis and HIV/AIDS. In our 
study, the presence of chronic diseases together with advanced cancer can be likened to 
 32 
‘tangible’ or direct sources of pain where relief can be directly addressed by specialized med-
ical personnel and different relevant interventions 
 
On the other side, apart from the obvious diagnosable sources of pain among cancer patients, 
other subtle sources have been identified to tremendously cause discomfort and pain among 
palliative cancer patients. These are areas associated with the environment, social and psy-
chosocial areas of life. Palliative cancer patients have been known to be affected by depres-
sion, anxiety, worries such as leaving young children or loved ones behind and feelings of guilt 
or even fears of life after death. When unresolved, such situations affect pain relief processes 
and greatly undermine the whole treatment process.  
This piece of evidence that highlights the importance of Non pharmacological and complimen-
tary methods involving multi- professional teams which are important in assessing and provid-
ing relief within their professional skills. Teams involved usually include different specialized 
medical doctors, physiotherapists, social workers, counselors, religious authorities and most 
importantly nurses. The role of the nurse in such instances is to identify the need for this 
multi-professional approach. Their role is very central because they have more contact with 
the patients. Nurses in hospitals and home settings are in the position to assess the sources of 
distress through observation, interaction with patients and significant others and hence to 
make recommendations to physicians in charge on the possible multidisciplinary approaches 
that could alleviate such situations. Nurses’ knowledge in pharmacology can also go a long 
way in enabling easy detection of drug interaction and side effects when making reports on 
the patients to physicians.  
 
In conclusion, pain relief is central to the duties of healthcare professionals. In the cancer 
palliative care as well as all other health care settings it worth to note that they are also eth-
ically obligated to relieve pain.  The researchers stand in agreement with the statement that 
“the challenge to pain reformers lies in moving people not in pain to acknowledge and treat 
those who are” (Blacksher, 2001). In the same vein, we are inclined to agree that “how we as 
healthcare professionals think about pain influences how we respond to it. Our ability and 
willingness to detect it, report it, hear it, trust it, and treat it relies, in part, on what we un-
derstand pain to be and to mean and therefore any effort to improve pain management will 
have to work not only at institutional, regulatory, and political levels but, simultaneously and 
explicitly, at the conceptual” (Blacksher, 2001). 
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7 Ethical considerations 
 
Since ethical values and considerations should be taken into account at all stages of the re-
search process(Oliver, 2010), the thesis topic was decided upon in the presence of two thesis 
supervisors on a thesis day. A thesis contract and plan was drawn up, written and forwarded 
to the thesis supervisor for approval. Prior to data research process, the methodology was 
agreed upon and studied in-depth by both researchers and a meeting with the librarian was 
arranged in a bid to guide the data search process. The thesis was written in stages and for-
warded to the supervisor for review and permission to progress through the next stages. This 
thesis produces valuable findings which are both relevant to the research question, purpose 
statement and aims of the study.  
This study wasa systematic literature review so there was no need for informed consent. 
There was also no participants-researcher relationships, confidentiality or anonymity issues to 
be considered (Oliver, 2010). 
In reference to gaining access, the information and research data was rightfully accessed with 
student passwords through the NELLI portal.  
The researchers were obligated to quote and reference the information sources in respect to 
owner publication rights. The data references were listed according to the Laurea guidelines 
in the reference section. 
Both researchers exercised ethical values throughout the process. The workload was fairly 
shared, there was mutual respect and accountability. There was no conflict of interest during 
the process. Bias was avoided during the research by both researchers producing ideas inde-
pendently on the same articles and later merging them into a common body.  
 
7.1 Trustworthiness 
 
For trustworthy information, four academic electronic databases were used to collect data 
through NELLI portal. These included PUBMED, CINAHL, Taylor & Francis, and SAGE. The data 
collection was conducted by two researchers. 
A Pre-defined protocol was in place to minimize possible researcher bias and the process was 
bench marked against the criteria at all times. Researchers found a common understanding 
areas of divided opinions by the two researchers were discussed until a consensus was 
reached.  
English was an agreed criterion which favoured full comprehension of the studies by both re-
searchers and thereby minimised misinterpretation and errors. 
 
Data was collected from full text articles written between 2006 and 2015 to ensure that in-
formation was based on current knowledge and information.  
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To avoid over generalisation of the results (Aveyard, 2010), Our discussion was largely based 
on our findings in an effort to answer our research question and In addition to that, we made 
efforts through our discussion to relate our findings to health care settings while emphasizing 
the role of the nurse as an important participant and contributor in our research topic. 
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8 Limitations and recommendations. 
 
Even though the aims and research of the purpose were fulfilled and research questions an-
swered, the thesis has its limitations. Acknowledging shortcomings in our research enables 
the reader to put our results into context  
We would like to point out that as novice researchers, we might have benefitted more from 
the use of more experienced researchers who would have aided us in a much broader search 
involving more databases, critique and bringing together of the literature (Aveyard 2010). 
Such efforts would however require extra financial resources and time which we unfortunate-
ly could not afford at this level of study. The major limitation of this study was the set crite-
rion/ predefined protocol that was to be followed in a way that it created boundaries that 
may have led to missing out on relevant and essential data as discussed below. 
 
The search being limited to articles in full text and in the English language due to translation 
time and interpretation precision excluded a lot of potentially relevant articles published on 
other languages.  
The time frame within which the articles had to be written also eliminated a lot of relevant 
data that this research could have benefited from. More still, for some articles there was lim-
ited access through other libraries.  
The study also suffered a lack of quality, evidence material. It produced a number of editori-
als, with weak evidence to support particular arguments. Only two of the articles presented 
first-hand research results. With this in perspective, we would like to point out that the lack 
of original qualitative and quantitative research papers for inclusion in our study makes the 
applicability of the results limited only to certain health care situations and settings. Further 
research would have to be done to augment on the results of this paper. 
 
Despite the above, our research topic provided the opportunity to share with the reader the 
findings of other studies and to relate our research question to the larger body of knowledge 
through highlighting a gap in the knowledge in cancer pain in palliative care. The data search 
found that a lot of articles addressed chronic cancer pain but only few really focused on can-
cer pain in palliative care and what patients want out of that care. For future studies, the 
writers recommend further research in the field of cancer pain in palliative care as specific 
research type studies on palliative care for cancer patients would give a better insight on why 
the high numbers of unrelieved pain in cancer patients continue to elude medical personnel.  
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Table of selected Literature 
 
source Research title Aim of study Type of study Main Findings/ significance of 
the study 
Strengths and 
limitations 
Chih-Yi Sun et al 
(2007) 
Overcoming Barriers 
to Cancer Pain Man-
agement: An Institu-
tional Change Mode 
pre-intervention findings 
related to barriers to 
pain management 
Qualitative research us-
ing interviews and par-
ticipants observation 
 
 
 
 
Barriers were focused around 
screening, documentation, re-
assessment, and follow-up of 
pain, Lackof referrals. Lack of 
referrals to supportive care 
services for patients was also 
noted.  
100 subjects were in-
terviewed 
Rowley. et al 
(2010) 
Review of Cancer Pain 
Management in Pa-
tients Receiving 
Maintenance Metha-
done Therapy 
 
 
 
 
 
 
 
 
Explore why patients on 
MMT have difficult to 
manage pain, the opti-
mal management of 
their pain, and the in-
creasing role of metha-
done as an analgesic 
agent in cancer pain. 
 
 
 
Qualitative research 
conducted using  a retro-
spective chart review 
In all, 80% of the patients had 
documented difficulty in pain 
management. All patients re-
quired adjuvant agents in addi-
tion to opioids to manage their 
pain. 
For 9 (75%) of the 12 patients, 
the dose of methadone did not 
change significantly throughout 
the course of their illness 
4-year study long of12 
patients’ study of sub-
jects referred to the 
palliative care service 
with cancer pain who 
were on MMT. All had 
difficult to control 
pain, and a third re-
quired 5 or more anal-
gesic agents. 
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Mori.M et al  
(2012) 
Unrelieved Pain and 
Suffering in Patients 
With Advanced Cancer 
knowledge of the risk 
factors for poor pain 
control 
 
 
 
Case presentation 
of patients with ad-
vanced cancer  
Multidimensional approach al-
lows multidimensional assess-
ment and treatment of cancer 
pain but also address the under-
lying psychosocial and or spir-
itual distress. 
Proposes an algorithm 
of multidimensional 
approach to unrelieved 
pain and suffering in 
patients with ad-
vanced cancer. 
Thapa.D et al  
(2011) 
Can-
cer pain management 
current status 
Aims to discuss reasons f
or under treatment, tool
s of pain assessment, can
cer pain 
and anxiety and possibly 
carve new approaches fo
r cancer pain manageme
nt in future. 
 
 
non-
systematic review article 
Poor resources in developing 
countries, unavailability of 
morphine, physicians 
opophobia, problems with 
communication, a multifaceted 
dynamic target 
Carves new approach-
es to the management 
of cancer pain.  
Gibbins J. et al 
(2014) 
What do patients with 
advanced incurable 
cancer want from the 
management of their 
pain?  A qualitative 
study 
To explore how patients 
with advanced cancer 
describe the control of 
pain and what they want 
from management of this 
pain 
 
 
 
 
Qualitative study using 
face-to-face interviews 
Four themes emerged: main-
taining role, self and independ-
ence; compromising/modifying 
expectations; role of healthcare 
professionals; and meaning of 
pain in context of advanced 
cancer. 
Twelve interviews took 
place which gave good 
insight.  
The number was how-
ever too small to rep-
resent the cancer pop-
ulation.  
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Manjiani.D et al 
(2014) 
Availability and Utili-
zation of Opioids for 
Pain Management: 
Global Issues 
 
 
seeks to clarify the chal-
lenges related to opioid 
delivery. The considera-
ble negative physical and 
mental consequences of 
chronic pain are dis-
cussed for the general 
and palliative care popu-
lation. 
Review article The improvement of pain edu-
cation in undergraduate and 
postgraduate training will bene-
fit patients and clinicians. The 
promise of new medications, 
along with the utilization of 
multimodal approaches, has the 
potential to provide effective 
pain relief to future generations 
of sufferers. 
Provides Comprehen-
sive guidelines for 
improvement.  
 
Baumrucker.J.S et al 
(2009) 
Diversion of Opioid 
Pain Medications at 
End-of-Life 
Highlight the dangers of 
opiod diversion at the 
end of life  
Case presentation  Opiate diversion in the home 
setting as a major contributing 
factor to unrelieved pain among 
cancer patients.  
Provides the social-
work , medical ,legal,  
nursing and ethics per-
spectives  on opiate 
diversions in the home 
setting.  
Rezk Y. et al  
(2011) 
Palliative Care in Gy-
naecologic Oncology 
 
Evaluation and allevia-
tion of pain in palliation  
 
 
 
Review article Highlights a real need for more 
emphasis on palliative care ed-
ucation in training programs 
addresses some of the 
common symptoms 
experienced by this 
group of patients in a 
practical manage-
ment-oriented ap-
proach 
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Ola Dale et al 
(2005) 
EU not united in opi-
oid use 
 
Highlight the underutili-
zation of step 3 opioids, 
as a cornerstone of 
symptomatic pain treat-
ment in cancer patients 
 
 
 
 
editorial (1) morphine is used little in 
comparison to the other drugs; 
(2) there are large variations in 
the use of opioids both in re-
spect to total consumption and 
choice of opioids between Eu-
ropean nations; (3) the trends 
with respect to an increase and 
decrease in the use of opioids 
vary between countries; and (4) 
opioid wholesale prices differ 
considerably between countries 
Benchmarks different 
opioid usage in Europe 
and how it affects the 
management of pain 
Gilson A. M et al 
(2012) 
Multivariate analysis 
of countries' govern-
ment and health-care 
system influences on 
opioid availability for 
cancer pain relief and 
palliative care 
examine countries’ gov-
ernment and health-care 
system influences on 
opioid availability for 
cancer pain and pallia-
tive care, as a means to 
identify implications for 
improving appropriate 
access to prescription 
opioids 
Multivariate study Findings demonstrate that a 
limited number of predictor 
variables characterizing a coun-
try’s government and health-
care system infrastructure can 
explain its opioid consumption 
level, with the greatest influ-
ence being very high Human 
Development Index. 
Uses different domains 
for analysis. Including 
acquisition, education, 
national policy, medi-
cation distribution 
guidelines. 
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